David P. Al-Adra, MD, PhD, FACS

Assistant Professor

  • Division of Transplantation 

aladra@surgery.wisc.edu
(608) 263-0388

Clinical Science Center
600 Highland Avenue
Madison WI 53792

Education

  • MD, University of Alberta
  • PhD, Clinical Investigator Program in the Department of Surgery, University of Alberta
  • Residency, General Surgery, University of Alberta
  • Abdominal Organ Transplant Fellowship, University of Toronto

Clinical Specialties

Dr. Al-Adra is certified by the American Board of Surgery (ABS), the American Society of Transplant Surgeons (ASTS), the Royal College of Surgeons of Canada, and the Americas Hepato-Pancreato-Biliary Association (AHPBA). He specializes in liver, kidney, pancreas and pediatric transplantation, live donor liver transplantation (LDLT), and hepatobiliary surgery.

Research Interests

Dr. Al-Adra is investigating the mechanisms of immunological rejection after solid organ transplantation. The goal of his research is to decrease the immune response against the organ, which would then decrease the need for anti-rejection drugs. Specifically, the transplanted organs can be modified using normothermic machine organ preservation technologies to decrease rejection after transplantation.

Learn more about Dr. Al-Adra’s lab here. 

Dr. Al-Adra was recently awarded a one-year, $65,000 grant from UW’s 2023 Fall Research Competition, which is administered by the Office of the Vice Chancellor for Research. Read more here.

Dr. Al-Adra received a new one-year, $50,000 Pilot Research Award from the American Association for the Study of Liver Diseases Foundation. Read more here.

Recent Publications

  • Predictors for postoperative dysphagia in liver transplant recipients.
    Isdahl M, Katz L, Johnson M, Leverson G, Al-Adra D, Thibeault S
    Front Transplant 2024; 3: 1415141
    [PubMed ID: 39221171]

  • Single cell RNA-sequencing identifies the effect of Normothermic ex vivo liver perfusion on liver-resident T cells.
    Al-Adra D, Lan R, Jennings H, Weinstein KN, Liu Y, Verhoven B, Zeng W, Heise G, Levitsky M, Chlebeck P, Liu YZ
    Transpl Immunol 2024 Oct; 86: 102104
    [PubMed ID: 39128812]

  • Normothermic liver perfusion derived extracellular vesicles have concentration-dependent immunoregulatory properties.
    Jennings H, McMorrow S, Chlebeck P, Heise G, Levitsky M, Verhoven B, Kink JA, Weinstein K, Hong S, Al-Adra DP
    J Extracell Vesicles 2024 Jul; 13(7): e12485
    [PubMed ID: 39051751]

  • Cancer Surveillance in Solid Organ Transplant Recipients With a Pretransplant History of Malignancy: Multidisciplinary Collaborative Expert Opinion.
    Watt KD, Rolak S, Foley DP, Plichta JK, Pruthi S, Farr D, Zwald FO, Carvajal RD, Dudek AZ, Sanger CB, Rocco R, Chang GJ, Dizon DS, Langstraat CL, Teoh D, Agarwal PK, Al-Qaoud T, Eggener S, Kennedy CC, D'Cunha J, Mohindra NA, Stewart S, Habermann TH, Schuster S, Lunning M, Shah NN, Gertz MA, Mehta J, Suvannasankha A, Verna E, Farr M, Blosser CD, Hammel L, Al-Adra DP
    Transplantation 2024 May 21;
    [PubMed ID: 38771067]

  • What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2023? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society.
    Bonaccorsi-Riani E, Ghinolfi D, Czigany Z, Dondossola D, Emamaullee J, Yuksel M, Boteon YL, Al-Adra D, Ho CM, Abdelrahim M, Pang L, Barbas A, Meier R, MacParland S, Sayed BA, Pavan-Guimaraes J, Brüggenwirth IMA, Zarrinpar A, Mas VR, Selzner M, Martins PN, Bhat M
    Transplantation 2024 May 01; 108(5): 1043-1052
    [PubMed ID: 38494468]

All Publications on PubMed